Treatment of the cerebral manifestations of arteriosclerosis with cyclandelate.
D000368:Aged; D000704:Analysis of Variance; D001519:Behavior; D001794:Blood Pressure; D002784:Cholesterol / Q000097:blood; D002986:Clinical Trials as Topic; D003510:Cyclohexanes / Q000627:therapeutic use*; D004569:Electroencephalography; D005260:Female; D006801:Humans; D007361:Intelligence Tests; D002537:Intracranial Arteriosclerosis / Q000188:drug therapy*; D008297:Male; D008333:Mandelic Acids / Q000627:therapeutic use*; D008568:Memory; D008875:Middle Aged; D010919:Placebos; D014665:Vasodilator Agents / Q000627:therapeutic use*; D014825:Vocabulary
D003510:Cyclohexanes; D008333:Mandelic Acids; D010919:Placebos; D014665:Vasodilator Agents; D002784:Cholesterol